Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
Clinical trial NCT02846532 · COMPLETED
Trial details
- NCT number
- NCT02846532
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-16
- Primary completion
- 2020-07-16
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.